![Mayo Clinic Q and A: Cold cap therapy can reduce hair loss caused by chemotherapy - Mayo Clinic News Network Mayo Clinic Q and A: Cold cap therapy can reduce hair loss caused by chemotherapy - Mayo Clinic News Network](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2018/01/a-medical-illustration-of-cold-cap-therapy-for-chemotherapy-patients-original.jpg)
Mayo Clinic Q and A: Cold cap therapy can reduce hair loss caused by chemotherapy - Mayo Clinic News Network
![JCM | Free Full-Text | Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today? JCM | Free Full-Text | Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?](https://www.mdpi.com/jcm/jcm-10-00128/article_deploy/html/images/jcm-10-00128-g001.png)
JCM | Free Full-Text | Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?
![Cryopyrin-Associated Periodic Syndrome (CAPS) - Amyloidosis Patient Information SiteAmyloidosis Patient Information Site Cryopyrin-Associated Periodic Syndrome (CAPS) - Amyloidosis Patient Information SiteAmyloidosis Patient Information Site](http://www.amyloidosis.org.uk/wp-content/uploads/2012/11/CAPS-rash.jpg)
Cryopyrin-Associated Periodic Syndrome (CAPS) - Amyloidosis Patient Information SiteAmyloidosis Patient Information Site
![Paxman announces that US Centers for Medicare and Medicaid Services (CMS) has maintained the payment rate for Scalp Cooling for 2023 - Paxman Paxman announces that US Centers for Medicare and Medicaid Services (CMS) has maintained the payment rate for Scalp Cooling for 2023 - Paxman](https://paxmanscalpcooling.com/wp-content/uploads/2022/11/download.png)
Paxman announces that US Centers for Medicare and Medicaid Services (CMS) has maintained the payment rate for Scalp Cooling for 2023 - Paxman
![Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production | Nature Communications Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-024-44990-0/MediaObjects/41467_2024_44990_Fig1_HTML.png)